Google disputes Texas' suit claiming unfair advertising sales practices

·1 min read
FILE PHOTO: A Google sign is pictured on a New York building

NEW YORK (Reuters) - Google said on Sunday that antitrust claims in a Texas lawsuit were "misleading," responding in a blog post as state attorneys general plan suits against the Alphabet Inc unit.

In December, Texas Attorney General Ken Paxton filed a complaint about Google's advertising technology business, in one of several suits alleging that Google abused its dominance of the internet search business or otherwise broke antitrust law.

In Sunday's blog post, Google's Economic Policy Director Adam Cohen said the company wanted to set the record straight and dispel myths about its open bidding process for advertising.

"AG Paxton tries to paint Google’s involvement in this industry as nefarious," Cohen wrote. "The opposite is true. Unlike some B2B companies in this space, a consumer internet company like Google has an incentive to maintain a positive user experience and a sustainable internet that works for all—consumers, advertisers and publishers."

The post argues that Google's rates are fair, the marketplace is open and does not favor a single partner, such as Facebook.

(Reporting By Jessica Resnick-Ault, Editing by Nick Zieminski)

Latest Stories

  • Matt Ritchie apologises after angry exchange with Newcastle boss Steve Bruce

    The 31-year-old came on as a substitute against Wolves.

  • Worldwide UHF RFID Industry to 2027 - Growth in IoT offers Market Opportunities - ResearchAndMarkets.com

    The "UHF RFID Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Component and Application" report has been added to ResearchAndMarkets.com's offering.

  • Democrats eye three progressive prosecutors for U.S. attorney posts

    Three Black female local prosecutors aligned with a movement to end racial disparities in the U.S. criminal justice system are seen as contenders for top federal prosecutor posts, sources said, a potential sign of how President Joe Biden aims to reform the Justice Department. Rachael Rollins in Boston, Sherry Boston in Atlanta and Satana Deberry in Durham, North Carolina have been approached by congressional Democrats or members of Biden's transition team about potentially leading some of the department's 93 U.S. Attorney's Offices, sources familiar with the matter said.

  • Covid: Brazil's daily deaths reach all-time high

    The daily toll reached 1,910 on Wednesday, Brazil's highest figure since the pandemic started.

  • OPEC cartel, allies face decision on increasing oil output

    Members of oil producer cartel OPEC and allied countries are weighing an increase in production now that prices have recovered to near their pre-pandemic levels. The so-called OPEC Plus - which includes countries like Russia that are not part of the cartel but have been coordinating production in recent years - made deep cuts in output in 2020 to stave off a complete collapse in prices. It decided to add back 500,000 barrels per day in December, and analysts say it's possible the gathered ministers could raise production by another 500,000 barrels per day.

  • Worldwide Textured Soy Protein Industry to 2026 - Non-GMO Textured Soy Protein to gain Prominence - ResearchAndMarkets.com

    The "Global Textured Soy Protein Market Growth, Trends and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.

  • Exclusive: Lithium giant Albemarle slams Chile over 'unjust' withholding of Atacama study

    Albemarle Corp, the world's top lithium producer, has accused a Chilean regulator of "unjust" discrimination for refusing to make public a key report on the impact of mining on the Atacama salt flat, according to court filings. U.S.-based Albemarle in July last year asked to see the publicly funded report but regulator Corfo rejected the request after Chilean miner SQM, a top competitor, objected on grounds it contained confidential information. Albemarle blasted that discrepancy in previously unreported arguments made before a Santiago appeals court in February, saying it resulted in "arbitrary, unjust, illegal, and above all, unconstitutional discrimination."

  • Myanmar coup: 'Everything will be OK' teenage protester mourned

    Kyal Sin, known as Angel, was one of 38 people killed in anti-coup protests on Wednesday.

  • Pepperdine Graziadio to Host 9th Annual SEER Symposium for Businesses to Seize the Moment on March 24

    Join Pepperdine Graziadio for its 9th Annual Socially, Environmentally, and Ethically Responsible (SEER) Symposium on Wednesday, March 24, 2021 from 11:30 AM to 1 PM. This year’s event theme, Seizing The Moment, will feature a powerhouse of industry-leading speakers to discuss the vital need for incorporating ethical, environmental, and sustainable practices within the evolving business landscape.

  • British Airways prepares for travel restart with testing kit plan

    British Airways has struck a deal with a COVID-19 testing kit provider as airlines prepare for the desperately-needed restart of summer travel, which is likely to include tests for passengers. But it is not yet clear how mass foreign travel will resume. British Airways (BA) said on Thursday its new testing deal would make it easier for travellers to take a test when abroad to fulfil any requirements for their return to Britain.

  • Dow Jones Futures: Why The Market Rally Is Only 'Mostly Dead'; Boeing Leads As Amazon, Zoom Break Long-Term Support

    The Nasdaq undercut lows while Amazon and stay-at-home winners like Zoom tumbled below 200-day lines. But the market rally isn't all dead yet.

  • UPDATE 1-Abu Dhabi's Mubadala takes orders for euro-denominated bonds - document

    Abu Dhabi state fund Mubadala began taking orders for two-tranche euro-denominated bonds comprising six- and 13-year paper, a document showed on Thursday. Initial guidance was around 85 basis points (bps) over mid-swaps for the six-year notes and between 105 and 110 bps over mid-swaps for the 13-year notes, the document from one of the banks on the deal showed. The bonds are being issued through Mamoura Diversified Global Holding (MDGH), a wholly-owned subsidiary of Mubadala Investment Company.

  • CEE MARKETS-Currencies, stocks weaker; new lockdown measures eyed in Hungary

    Most Central European currencies and stocks weakened on Thursday as a turnaround in U.S. bond yields dented risk appetite, while markets eyed further lockdown measures in Hungary to curb the spread of the new coronavirus. The Hungarian forint dropped 0.2% at 364.7500 per euro, while the Polish zloty fell 0.1%. "The Polish zloty is suffering from the epidemic situation, where restrictions are still maintained due to the increase in cases related to the third wave of the pandemic."

  • Cherries Wild: Cara & Gwen Want To Buy An Italian House

    Hosted by Jason Biggs, CHERRIES WILD is a fast-paced half-hour game show that features two rounds of pop culture trivia gameplay. This week's contestants, Gwen and Cara, try and "Solve the Slots" in hopes of getting one step closer to winning the $250,000 jackpot. Watch as this female duo spins the reels on the enormous slot machine, as they attempt to capture all five Wild Cherries to win the ultimate prize.

  • Worried about climate change? There's a book for that.

    Books titled “Trees in Trouble” and “How We’re F—ing Up Our Planet” scream out from the shelves of Barnes and Noble’s nature and wildlife section between reassuring tomes on hummingbirds and wildflowers. As the warming world faces raging forest fires, rising seas and increasingly erratic weather, the United States has seen a boom in books about climate change. A Yale University survey released in December found that 66% of Americans were either somewhat or very worried about climate change, up from 53% in 2011.

  • Insights on the Point of Care Diagnostics Global Market to 2028 - by Platform, End-use, Product and Regions

    Dublin, March 04, 2021 (GLOBE NEWSWIRE) -- The "Point of Care Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Platform; By End-Use; By Product; By Regions; Segment Forecast, 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global Point of Care (PoC) diagnostics market is expected to reach US$ 24.70 billion by 2028, according to the study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.The global Point of Care (PoC) diagnostics market is driven by continuous technological advancement in the form of miniaturization of devices, growing preference of patients towards home care, and consistent decline in prices due to inflow of innovative market players. Price reduction increases product penetration, owing to higher affordability among consumers.The growing prevalence of target diseases such as cancer, diabetes, cardiovascular diseases and infectious diseases is expected to drive Point of Care (PoC) diagnostics industry. Cardiovascular diseases are one of the most fatal disorders and are the leading cause of death across the globe. The high presence of unmet medical needs pertaining to this disease and the subsequent rise observe in patient awareness levels in this region is expected to boost the demand for Point of Care (PoC) diagnostics.Segment Highlights Glucose testing segment accounted for the largest revenue share in 2020. Regular glucose testing is of paramount importance for diabetic patients. As per the Diabetes Control and Complications Trial, the use of blood glucose monitors leads to lesser disease complications. Point of Care (PoC) glucose monitors assisting in periodic monitoring of blood glucose helps doctors decide suitable treatment patterns.Clinics were the largest end-use segment accounting for major market share in 2020. High procedure volumes associated with these establishments is one of the primary reasons attributing to its large share.North America was the largest regional market for revenue generation in from Point of Care (PoC) devices in 2020. Growing geriatric population base and the presence of higher medical expenditure levels are some key factors attributing to its largest share.The leading players in the point of care (PoC) diagnostic market include Sekisui Diagnostics LLC, Trinity Biotech PLC, International Technidyne Corporation (ITC), Nipro Diagnostics Inc, Becton Dickinson & Company, Danaher Corporation, Siemens Healthcare GmbH, Roche Ltd. Key Topics Covered: 1. Introduction1.1. Report Description1.1.1. Objectives of the Study1.1.2. Market Scope1.1.3. Assumptions1.2. Stakeholders2. Executive Summary2.1. Market Highlights3. Research Methodology3.1. Overview3.1.1. Data Mining3.2. Data Sources3.2.1. Primary Sources3.2.2. Secondary Sources4. Point of Care (PoC) Diagnostics Market Insights4.1. Point of Care (PoC) Diagnostics - Industry snapshot4.2. Point of Care (PoC) Diagnostics Market Dynamics4.2.1. Drivers and Opportunities4.2.1.1. Growing prevalence of infectious diseases4.2.1.2. Rising preference towards home healthcare4.2.2. Restraints and Challenges4.2.2.1. Product recalls4.3. Porter's Five Forces Analysis4.3.1. Bargaining Power of Suppliers (Moderate)4.3.2. Threats of New Entrants: (Low)4.3.3. Bargaining Power of Buyers (Moderate)4.3.4. Threat of Substitute (Moderate)4.3.5. Rivalry among existing firms (High)4.4. PESTLE Analysis4.5. Point of Care (PoC) Diagnostics Market Industry trends5. Point of Care (PoC) Diagnostics Market Assessment by Product5.1. Key Findings5.2. Introduction5.2.1. Global Point of Care (PoC) Diagnostics Market, By Product, 2016-2028 (USD Million)5.3. Glucose Testing5.3.1. Global Point of Care (PoC) Diagnostics Market, by Glucose Testing, by Region, 2016-2028 (USD Million)5.4. Hb1Ac Testing5.4.1. Global Point of Care (PoC) Diagnostics Market, by Hb1Ac Testing, by Region, 2016-2028 (USD Million)5.5. Coagulation5.5.1. Global Point of Care (PoC) Diagnostics Market, by Coagulation, by Region, 2016-2028 (USD Million)5.6. Fertility5.6.1. Global Point of Care (PoC) Diagnostics Market, by Fertility, by Region, 2016-2028 (USD Million)5.7. Infectious Diseases5.7.1. Global Point of Care (PoC) Diagnostics Market, by Infectious Diseases, by Region, 2016-2028 (USD Million)5.7.2. HIV5.7.2.1. Global Point of Care (PoC) Diagnostics Market, by HIV, by Region, 2016-2028 (USD Million)5.7.3. Clostridium Difficile5.7.3.1. Global Point of Care (PoC) Diagnostics Market, by Clostridium Difficile, by Region, 2016-2028 (USD Million)5.7.4. HBV5.7.4.1. Global Point of Care (PoC) Diagnostics Market, by HBV, by Region, 2016-2028 (USD Million)5.7.5. Cardiac Markers5.7.5.1. Global Point of Care (PoC) Diagnostics Market, by Cardiac Markers, by Region, 2016-2028 (USD Million)5.7.6. Thyroid Stimulating Hormone5.7.6.1. Global Point of Care (PoC) Diagnostics Market, by Thyroid Stimulating Hormone, by Region, 2016-2028 (USD Million)5.7.7. Hematology5.7.7.1. Global Point of Care (PoC) Diagnostics Market, by Hematology, by Region, 2016-2028 (USD Million)5.7.8. Primary Care Systems5.7.8.1. Global Point of Care (PoC) Diagnostics Market, by Primary Care Systems, by Region, 2016-2028 (USD Million)5.7.9. Decentralized Clinical Chemistry5.7.9.1. Global Point of Care (PoC) Diagnostics Market, by Decentralized Clinical Chemistry, by Region, 2016-2028 (USD Million)5.7.10. Feces5.7.10.1. Global Point of Care (PoC) Diagnostics Market, by Feces, by Region, 2016-2028 (USD Million)5.7.11. Lipid Testing5.7.11.1. Global Point of Care (PoC) Diagnostics Market, by Lipid Testing, by Region, 2016-2028 (USD Million)5.7.12. Cancer Marker5.7.12.1. Global Point of Care (PoC) Diagnostics Market, by Cancer Marker, by Region, 2016-2028 (USD Million)5.7.13. Blood Gas/Electrolytes5.7.13.1. Global Point of Care (PoC) Diagnostics Market, by Blood Gas/Electrolytes, by Region, 2016-2028 (USD Million)5.7.14. Ambulatory Chemistry5.7.14.1. Global Point of Care (PoC) Diagnostics Market, by Ambulatory Chemistry, by Region, 2016-2028 (USD Million)5.7.15. Drug Abuse Testing5.7.15.1. Global Point of Care (PoC) Diagnostics Market, by Drug Abuse Testing, by Region, 2016-2028 (USD Million)5.7.16. Urinalysis5.7.16.1. Global Point of Care (PoC) Diagnostics Market, by Urinalysis, by Region, 2016-2028 (USD Million)6.7. Global Point of Care (PoC) Diagnostics Market, by Platform7.1. Key Findings7.2. Introduction7.2.1. Global Point of Care (PoC) Diagnostics Market, By Platform, 2016-2028 (USD Million)7.3. Lateral Flow Assays7.3.1. Global Point of Care (PoC) Diagnostics Market, by Lateral Flow Assays, By Region, 2016-2028 (USD Million)7.4. Dipsticks7.4.1. Global Point of Care (PoC) Diagnostics Market, by Dipsticks, by Region, 2016-2028 (USD Million)7.5. Microfluidics7.5.1. Global Point of Care (PoC) Diagnostics Market, by Microfluidics, by Region, 2016-2028 (USD Million)7.6. Molecular Diagnostics7.6.1. Global Point of Care (PoC) Diagnostics Market, by Molecular Diagnostics, by Region, 2016-2028 (USD Million)7.7. Immunoassays7.7.1. Global Point of Care (PoC) Diagnostics Market, by Immunoassays, by Region, 2016-2028 (USD Million)8. Global Point of Care (PoC) Diagnostics Market, by End-Use8.1. Key Findings8.2. Introduction8.2.1. Global Point of Care (PoC) Diagnostics Market, By End-Use, 2016-2028 (USD Million)8.3. Clinics8.3.1. Global Point of Care (PoC) Diagnostics Market, by Clinics, By Region, 2016-2028 (USD Million)8.3.2. Physician Office8.3.2.1. Global Point of Care (PoC) Diagnostics Market, by Physician Office, By Region, 2016-2028 (USD Million)8.3.3. Pharmacy & Retail Clinics8.3.3.1. Global Point of Care (PoC) Diagnostics Market, by Pharmacy & Retail Clinics, By Region, 2016-2028 (USD Million)8.3.4. Non-practice Clinics8.3.4.1. Global Point of Care (PoC) Diagnostics Market, by Non-practice Clinics, By Region, 2016-2028 (USD Million)8.3.5. Urgent Care Clinic8.3.5.1. Global Point of Care (PoC) Diagnostics Market, by Urgent Care Clinic, By Region, 2016-2028 (USD Million)8.4. Hospitals8.4.1. Global Point of Care (PoC) Diagnostics Market, by Hospitals, By Region, 2016-2028 (USD Million)8.5. Home8.5.1. Global Point of Care (PoC) Diagnostics Market, by Home, by Region, 2016-2028 (USD Million)8.6. Assisted Living Healthcare Facilities8.6.1. Global Point of Care (PoC) Diagnostics Market, by Assisted Living Healthcare Facilities, by Region, 2016-2028 (USD Million)8.7. Laboratory8.7.1. Global Point of Care (PoC) Diagnostics Market, by Laboratory, by Region, 2016-2028 (USD Million)9. Point of Care (PoC) Diagnostics Market Assessment by Geography9.1. Key findings9.2. Introduction9.2.1. Point of Care (PoC) Diagnostics Market Assessment, By Geography, 2016-2028 (USD Million)9.3. Point of Care (PoC) Diagnostics Market - North America9.4. Point of Care (PoC) Diagnostics Market - Europe9.5. Point of Care (PoC) Diagnostics Market - Asia-Pacific9.6. Point of Care (PoC) Diagnostics Market - Middle East & Africa9.7. Point of Care (PoC) Diagnostics Market - Latin America10. Competitive Landscape10.1. Expansion and Acquisition Analysis10.1.1. Expansion10.1.2. Acquisition10.2. Partnerships/Collaborations/Agreements/Exhibitions11. Company Profiles11.1. Roche Diagnostics11.1.1. Company Overview11.1.2. Financial Performance11.1.3. Product Benchmarking11.1.4. Recent Developments11.2. Abbott Laboratories11.2.1. Company Overview11.2.2. Financial Performance11.2.3. Product Benchmarking11.2.4. Recent Developments11.3. Siemens Healthcare11.3.1. Company Overview11.3.2. Financial Performance11.3.3. Product Benchmarking11.3.4. Recent Developments11.4. Becton, Dickinson and Company11.4.1. Company Overview11.4.2. Financial Performance11.4.3. Product Benchmarking11.4.4. Recent Developments11.5. Johnson & Johnson11.5.1. Company Overview11.5.2. Financial Performance11.5.3. Product Benchmarking11.5.4. Recent Developments11.6. Danaher Corporation11.6.1. Company Overview11.6.2. Financial Performance11.6.3. Product Benchmarking11.6.4. Recent Developments11.7. Chembio Diagnostic Systems11.7.1. Company Overview11.7.2. Financial Performance11.7.3. Product Benchmarking11.7.4. Recent Developments11.8. EKF Diagnostics11.8.1. Company Overview11.8.2. Financial Performance11.8.3. Product Benchmarking11.8.4. Recent Developments11.9. AccuBioTech11.9.1. Company Overview11.9.2. Financial Performance11.9.3. Products/Product Benchmarking11.9.4. Recent DevelopmentsFor more information about this report visit https://www.researchandmarkets.com/r/f9iq1x CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • World IoT Data Management and Analytics Markets, 2021-2026: Business Automation Functionality, Revenue and Profitability will Improve via IoT Data Analytics Market Solutions - ResearchAndMarkets.com

    The "IoT Data Management and Analytics Market by Technology, Infrastructure, Deployment Model (Cloud vs. Premise), Solutions, Applications and Services in Industry Verticals 2021 - 2026" report has been added to ResearchAndMarkets.com's offering.

  • Neobroker nextmarkets receives $30 million in Series B funding round

    nextmarkets, the innovative and commission-free online broker, receives $30 million in a Series B financing round. The additional capital is intended to further accelerate the European expansion of the FinTech company, which was founded in Cologne in 2014, and to establish nextmarkets as the leading neobroker in Europe. In addition to Germany and Austria, six further countries - the United Kingdom, Portugal, the Netherlands, France, Spain and Italy - were launched at the end of 2020. The financing round closes out a successful 2020 financial year for nextmarkets, in which the company was able to multiply all KPIs such as the number of executed transactions, customer deposits, as well as the number of customers.

  • FC Barcelona loses EU bid to overturn state aid claim

    Barcelona football club on Thursday lost a bid before the EU's top court to overturn a claim it received unfair state aid through tax breaks.

  • Security tight at U.S. Capitol after police warn of possible militia attack

    Security has been tightened around the U.S. Capitol in Washington - scene of a deadly assault in January - after police warned that a militia group might try to attack it on Thursday, an important day in the calendar for some pro-Trump conspiracy theorists. March 4 is the day when believers in the baseless QAnon conspiracy have claimed that former President Donald Trump, defeated by President Joe Biden in the Nov. 3 election, will be sworn in for a second term in office. An unidentified group of "militia violent extremists" discussed plans in February to "take control of the U.S. Capitol and remove Democratic lawmakers on or about March 4," according to a bulletin issued on Tuesday by the Department of Homeland Security and the Federal Bureau of Investigation.